These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4388629)

  • 41. The effect of methylphenidate on the sleep-wake cycle of brain-injured patients undergoing rehabilitation.
    Al-Adawi S; Burke DT; Dorvlo AS
    Sleep Med; 2006 Apr; 7(3):287-91. PubMed ID: 16564212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T; Doyle R; Surman C; Prince J; Mick E; Aleardi M; Herzig K; Faraone S
    Biol Psychiatry; 2005 Mar; 57(5):456-63. PubMed ID: 15737659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medication for children with attention disorders.
    Kash IJ
    Pediatrics; 1997 Jun; 99(6):922-3. PubMed ID: 9164792
    [No Abstract]   [Full Text] [Related]  

  • 45. The use of psychostimulants in general psychiatry. A reconsideration.
    Chiarello RJ; Cole JO
    Arch Gen Psychiatry; 1987 Mar; 44(3):286-95. PubMed ID: 2881528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children.
    Swanson J; Gupta S; Guinta D; Flynn D; Agler D; Lerner M; Williams L; Shoulson I; Wigal S
    Clin Pharmacol Ther; 1999 Sep; 66(3):295-305. PubMed ID: 10511066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Methylphenidate in palliative care in cancer patient: a double-blind randomised trial versus placebo].
    Laval G; Paris A
    Bull Cancer; 2008 Feb; 95(2):241-6. PubMed ID: 18304907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Narcolepsy.
    Ware JC
    Va Med Q; 1996; 123(4):251-3, 255. PubMed ID: 8909146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methylphenidate use and divorce.
    Schultz BK
    CMAJ; 2007 Sep; 177(7):751; author reply 751. PubMed ID: 17893352
    [No Abstract]   [Full Text] [Related]  

  • 52. Influences of cylert upon memory changes with ECT.
    Small IF; Sharpley P; Small JG
    Am J Psychiatry; 1968 Dec; 125(6):837-40. PubMed ID: 4386991
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation of treatment with stimulants in narcolepsy.
    Mitler MM
    Sleep; 1994 Dec; 17(8 Suppl):S103-6. PubMed ID: 7701190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pemoline and methylphenidate in midly depressed outpatients.
    Rickels K; Gordon PE; Gansman DH; Weise CC; Pereira-Ogan JA; Hesbacher PT
    Clin Pharmacol Ther; 1970; 11(5):698-710. PubMed ID: 5455633
    [No Abstract]   [Full Text] [Related]  

  • 55. A research report on the anti-fatigue effects of magnesium pemoline.
    Orzack MH; Taylor CL; Kornetsky C
    Psychopharmacologia; 1968; 13(5):413-7. PubMed ID: 4388124
    [No Abstract]   [Full Text] [Related]  

  • 56. [Psychotropic drugs in the contemporary psychiatric treatment].
    Brzezicki E
    Neurol Neurochir Psychiatr Pol; 1965; 15(4):565-71. PubMed ID: 4378896
    [No Abstract]   [Full Text] [Related]  

  • 57. [Diazepam and reaction time in patients with neuroses].
    Borys B
    Psychiatr Pol; 1986; 20(5):364-8. PubMed ID: 3295922
    [No Abstract]   [Full Text] [Related]  

  • 58. [Possibilities of therapeutic control of exhaustion states and psychoneurotic disorders].
    Michalová C
    Psychiatr Neurol Med Psychol (Leipz); 1965 Jun; 17(6):225-32. PubMed ID: 4378600
    [No Abstract]   [Full Text] [Related]  

  • 59. Performance tests of amnesic patients with cylert.
    Talland GA; Hagen DQ; James M
    J Nerv Ment Dis; 1967 May; 144(5):421-9. PubMed ID: 4382435
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use of azoxodon in obstetric and gynecologic praxis].
    Rembez IM; Sas IuV; Nahorna VF; Iampol's'ka VI
    Pediatr Akus Ginekol; 1968 Jan; 1():55-7. PubMed ID: 4386036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.